 | | | The overarching mission of the CRSP is to enable the pivotal link in translational science between basic science and disease-oriented research. The CRSP will provide clinical research facilities to support Northwestern University’s (NU) clinical researchers who require a dedicated research facility with well-developed research resources and well-trained staff. The CRSP will also provide novel resources to investigators who currently lack core support services to move their research findings from the stage of research discovery to the clinic or from the clinic to the community. New CRSP core facilities will provide enhanced infrastructure for existing areas of research strength at Northwestern, as well as provide new resources to evaluate patient-oriented functional outcome measurements. Provide flexible and integrated research resources in Northwestern’s new CRSP to enable new as well as established collaborations between basic and clinical scientists, to enhance rapid translation of discovery into practice, to support a broad portfolio of study designs, and to facilitate recruitment of diverse patient populations. Establish best practices to ensure that all studies using the CRSP meet the highest standards for quality of science, statistical rigor, ethical practices, and participant safety. Collaborate with investigators and NUCATS Institute senior leadership to continuously enhance and facilitate translational research programs.
A major focus of the CRSP is the transformation of our existing GCRC into a new entity that is better-positioned to meet the changing needs of NU’s clinical and translational research community. While a centralized clinical facility for more intensive clinical research studies will continue to be a feature of the new CRSP, the CRSP will transform NU’s clinical research enterprise by working with the other components of the NUCATS Institute to make clinical research resources available in a variety of settings through satellite facilities based in the community and outpatient clinics to support less intensive clinical studies. A particularly important connection for the new CRSP will involve the NUCATS Community-Engaged Research Center. The new CRSP will enhance existing research programs and enable new ones by providing innovative core resources. Transformation of the GCRC into the CRSP will also facilitate integration of ongoing clinical research operations at NU with the other program within the Center for Clinical Research, the Regulatory Support Program. Rosalind Ramsey-Goldman, MD, DrPH, serves as the program director and is responsible for the clinical research facility of the CRSP. She is a professor of medicine and current program director of NU’s GCRC. Her clinical research focuses on the long-term consequences of systemic lupus erythematosus (SLE), its prevention and complications. Dr. Ramsey-Goldman is principal investigator for the Patient-Oriented Clinical Research Program in SLE at Northwestern. This research program is mainly funded by NIH grants (P60, PO1, RO3, U01, K24 project and core grants) and private foundations. Dr. Ramsey-Goldman has published over 100 peer-reviewed and invited papers. She serves as the associate director of the Multidisciplinary Clinical Research Center in Rheumatology and co-director of clinical research training for the NIH-funded T32 Rheumatology Training Grant at the University. She has been a mentor for NU’s NIH-funded K12 Mentored Clinical Research Scholar Grant. As a mentor, she has guided more than 20 medical students, residents, graduate students, rheumatology fellows, and junior faculty. Her mentoring talents have been recognized by an NIH-funded K24 mentor award that has received 2 rounds of competitive funding. Dr. Ramsey-Goldman was named as a Kirkland Scholar Awardee in 2006, a national honor awarded to a senior SLE investigator in recognition of clinical research accomplishments and leadership in motivating young investigators to direct research careers towards SLE. She chairs the SLE International Collaborating Clinics group and is a standing member of the Neurological, Aging and Musculoskeletal Epidemiology study section at NIH. | |
